Arianna Aruanno

Plain English
Researchers created a new tool called the Asthma Awareness Questionnaire (AAQ) to better understand how patients with mild to moderate asthma think and feel about their condition. They found that overall awareness scores were low, averaging around 60 out of 100, although knowledge about asthma was slightly better, nearing 80. This tool helps identify areas where patients need more support, which can lead to improved asthma management. Who this helps: This benefits asthma patients by providing insights for better self-management strategies.

Plain English
This study looked at 17 adults in Rome who have both allergies and long COVID, focusing on specific biomarkers related to allergic inflammation and the integrity of bodily barriers. The researchers found that participants had varying levels of these biomarkers, with an average blood eosinophil count of about 179 cells per microliter and total immunoglobulin E (IgE) levels averaging 165.4 kU/L. Those with higher levels of a specific marker (ECP) and free light chains reported more severe long COVID symptoms, such as fatigue and difficulty breathing, lasting more than six months. Who this helps: This research is beneficial for patients with allergies and long COVID, as it could guide treatment options.

Plain English
This study looked at 679 patients with mild to moderate asthma to better understand their health, quality of life, and how well their asthma is controlled. The researchers found that 84.2% of these patients had moderate asthma, and about 26.3% of those patients were not adequately controlled despite treatment. This is important because many patients are still struggling with their asthma, which affects their daily lives and overall well-being. Who this helps: This helps asthma patients and their doctors by highlighting the need for better management and treatment options.

Plain English
This study looked at a rare condition called eosinophilic ascites (EA), which occurs when there is a high number of eosinophils, a type of white blood cell, in the fluid in the abdomen. The researchers found three patients at their hospital with EA linked to eosinophilic gastrointestinal diseases (EGIDs) and reviewed a total of 105 similar cases documented in scientific literature. These findings matter because EA can indicate serious underlying health issues, and recognizing it early can lead to effective treatments, like steroids and specific medications targeting eosinophils. Who this helps: Patients with eosinophilic gastrointestinal diseases and their doctors.

Plain English
This study looked at how common allergic reactions are among cancer patients using platinum-based drugs and taxanes, which are typical cancer treatments. Researchers evaluated 276 patients and found that 114 of them had positive allergy skin tests, with 64% of those reactions linked to platinum compounds compared to only 9.9% for taxanes. These findings show that allergy testing is crucial because it helps doctors choose the right treatments for patients who experience these reactions. Who this helps: This benefits cancer patients who may need alternative therapies if they have allergies to specific chemotherapy drugs.

Plain English
This study examined how adults with severe asthma who did not improve on other treatments responded after switching to the medication dupilumab. After one year, results showed that lung function improved by about 10.8%, levels of certain inflammatory markers dropped significantly, and 20% of patients achieved complete remission. This is important because it indicates that switching to dupilumab can be an effective option for people struggling with severe asthma who haven't done well with other medications. Who this helps: This helps patients with severe asthma who haven't responded well to their initial treatments.

Plain English
This study looked at allergic reactions to a drug called ocrelizumab, which is used to treat multiple sclerosis. Out of 387 patients, 94 experienced infusion-related reactions, and 6 cases were identified as IgE-mediated allergic reactions, meaning they were triggered by the immune system's response to the drug. Patients with a history of allergies were more likely to have these reactions, and switching to another drug called ofatumumab was generally safe and well-tolerated for those affected. Who this helps: Patients with multiple sclerosis and a history of allergies who are being treated with ocrelizumab.

Plain English
This study examined how some people can have an immediate allergic reaction to a muscle relaxant called thiocolchicoside. Researchers confirmed one patient's allergy using specific skin tests and a blood test, showing that thiocolchicoside can cause these reactions in rare cases. This finding is important because it highlights the need for better testing methods for such rare drug allergies to ensure patient safety. Who this helps: This helps patients who may be allergic to thiocolchicoside and doctors who prescribe it.

Plain English
This study looked at a man who had a severe allergic reaction while under general anesthesia due to chlorhexidine, a common antibacterial agent. Despite skin tests giving misleading results, laboratory tests successfully confirmed he was allergic to chlorhexidine by detecting specific antibodies and using a method to assess cell activation. This is important because it helps doctors diagnose allergic reactions to chlorhexidine more accurately, especially when skin tests don't work. Who this helps: This helps doctors and patients who may have allergies to chlorhexidine.

Plain English
This study looked at a specific drug called SonoVue, which is used during ultrasound procedures to improve the quality of images by making fluids easier to see. The researchers shared a case where a patient had a severe allergic reaction (anaphylaxis) after receiving SonoVue and reviewed 13 other similar cases found in the literature. They found that it is crucial for medical professionals to recognize and respond quickly to these dangerous reactions, as SonoVue is widely used. Who this helps: This helps doctors and healthcare providers who administer SonoVue to be better prepared for potential allergic reactions in patients.

Plain English
Researchers in Italy studied how skin tests for two substances, polyethylene glycol (PEG) and polysorbate 80 (PS-80), can help identify patients at risk of allergic reactions to COVID-19 vaccines. They tested 531 patients, discovering that only a small number (0.02%) of patients with a history of drug allergies reacted positively to these substances, while 7.1% of those who had suspected allergic reactions to COVID-19 vaccines did. This shows that most patients with a history of immediate allergic reactions likely don't have sensitivity to these excipients, which means doctors rely more on patient histories rather than these skin tests before vaccination. Who this helps: This helps patients who may be concerned about getting vaccinated due to past allergic reactions.

Plain English
The study looked at how to define "remission" for people with severe asthma, a condition that affects about 10% of asthma patients and can lead to serious health issues. Researchers consulted 80 experts and found that for complete remission, patients should not need oral steroids, and have no symptoms or attacks, while partial remission requires just some of these criteria to be met. This clear definition helps in evaluating how well different treatments work for severe asthma patients. Who this helps: This benefits patients with severe asthma and their doctors by providing clear treatment goals.

Plain English
This study looked at allergic reactions in cancer patients who were treated with a drug called paclitaxel, finding that about 6% of gynecologic cancer patients and 4% of breast cancer patients experience immediate hypersensitivity reactions (iHSRs). Researchers developed a new test, called a basophil activation test (BAT), which shows promise in identifying these allergic reactions; it was able to correctly identify 90.91% of patients with reactions to paclitaxel and 78.57% of those with reactions to another drug called carboplatin. This is important because it could help improve how doctors manage drug allergies in cancer patients by offering better diagnostic tools. Who this helps: Patients undergoing cancer treatment.

Plain English
This study examined peanut allergy in Italy to better understand its characteristics and the proteins causing allergic reactions. Researchers gathered data from 395 patients and found that about 38% had serious reactions, including anaphylaxis. The most common protein that triggered allergies was Ara h 9, affecting 77% of patients, while sensitization to certain proteins led to more severe symptoms, particularly in younger patients in northern Italy. Who this helps: This information benefits patients with peanut allergies and their doctors by providing insights into the specific characteristics of peanut allergies in Italy.

Plain English
This study looked at allergic reactions to two types of medical dyes used in imaging tests: iodinated contrast media (ICM) and gadolinium-based contrast media (GBCM). Researchers studied 350 patients with mild to moderate allergic reactions and found that those with GBCM reactions often had more respiratory and food allergies, while those with ICM reactions typically had more heart disease or cancer history. Over a five-year follow-up, 7.1% of patients experienced new allergic reactions even after testing negative, indicating that these reactions can persist despite precautions. Who this helps: This helps patients with a history of allergic reactions to medical dyes and their doctors in managing future imaging tests.

Plain English
This study looked at shrimp-allergic patients to see how many also react to mollusks, like clams and octopus. Out of 247 patients, nearly half (about 48%) reported having adverse reactions to eating mollusks. The study found that existing tests are not very effective at detecting all patients with mollusk allergies, as some patients didn't show any reaction to the tests despite having allergies. Who this helps: This research helps patients with shellfish allergies, doctors diagnosing these allergies, and food safety guidelines.

Plain English
This study looked at how well adults with allergies to lipid transfer proteins (found in many plants) used their prescribed epinephrine auto-injectors for allergic reactions. Out of 165 patients, only 1.7% used their auto-injector, even though 68 allergic reactions were recorded over three years, mostly mild but some severe. The findings highlight that many patients were prescribed auto-injectors unnecessarily, showing a need for better monitoring to ensure patients understand how and when to use them. Who this helps: This helps patients with food allergies and their doctors.

Plain English
This study looked at how patients with latex allergies experienced allergic reactions during the COVID-19 pandemic and whether continuing latex immunotherapy helped them. Among 67 patients, 34% experienced hives or swelling, 24% had respiratory issues, and 18% faced serious allergic reactions. Those who received continuous latex immunotherapy had significantly fewer allergic reactions and better quality of life compared to those who didn't. Who this helps: This benefits patients with latex allergies by providing evidence on how to manage their condition during health crises.

Plain English
This study looked at two commercial peach extracts to see how well they work for skin testing in diagnosing peach allergies related to a specific protein called lipid transfer protein (LTP). The researchers found that both extracts were very effective, identifying nearly all patients with a stable peach allergy while showing negative results for those allergic to less stable proteins. This matters because it allows doctors to quickly and accurately diagnose peach allergies during the first appointment. Who this helps: This helps patients with suspected peach allergies and their doctors.

Plain English
This study looked at how many patients with allergies to Italian cypress pollen are also allergic to a specific protein found in peaches called peamaclein. Out of 835 patients tested, only 24 (about 2.8%) were likely allergic to peamaclein alone. Most of these patients had previous food allergies, especially to peaches, and the study indicates that allergies to peamaclein are uncommon in Italy, with peach being the main concern. Who this helps: This helps patients who have cypress pollen allergies and may be concerned about peach allergies.

Plain English
This study examined patients who had serious allergic reactions to certain plant-based foods, focusing on potential triggers like medications and dietary factors. Researchers looked at 89 patients and found that 20 of them had multiple serious allergic reactions, often related to foods like tree nuts and soymilk. Notably, they discovered that nearly 1 in 5 patients were taking a specific type of stomach medication when they experienced these reactions, and consuming soymilk was more common among these patients than those without severe allergies. Who this helps: This information benefits patients with food allergies, particularly those sensitive to PR-10 and profilin, and their healthcare providers.

Plain English
This study focuses on a case of an 18-year-old man who had severe symptoms like muscle pain, skin bruising, and bleeding gums due to scurvy, which is a vitamin C deficiency. Tests showed he had very low levels of vitamin C in his blood. The case highlights that scurvy can occur in people who restrict their diets, especially if they also have related health issues like anxiety or celiac disease. Who this helps: This helps patients with restrictive diets or related health conditions.

Plain English
This study looked at four patients who had immediate allergic reactions to gadolinium-based contrast agents (GBCAs) during MRI scans. These reactions involved skin symptoms and pointed to the immune system playing a key role. Understanding these allergic responses is important because it helps ensure patient safety during MRI procedures. Who this helps: This benefits patients who may be at risk for allergic reactions to GBCAs.

Plain English
This study looked at allergic reactions to midazolam, a medication often used for sedation during procedures. Researchers collected data on five patients who experienced allergies to midazolam, confirmed through skin tests. Understanding these reactions is important because it can help healthcare providers identify and manage patients who are at risk for severe allergies to this common drug. Who this helps: This helps patients who may be allergic to midazolam and doctors who need to ensure safe sedation practices.

Plain English
This study looked at the connection between house dust mite allergies and shrimp allergies in 526 patients with house dust mite allergies. They found that 9% of these patients also had a shrimp allergy, compared to none in a control group. The research indicates that those allergic to shrimp often have higher levels of specific antibodies, which suggests that being sensitive to house dust mites increases the risk of developing a shrimp allergy. Who this helps: This information benefits allergy specialists and patients with house dust mite allergies.

Plain English
This study looked at how common allergies to plant lipid transfer proteins (LTPs) are in children. Researchers found that LTP allergies are becoming more recognized in kids, especially in areas like the Mediterranean, where these allergens are common. Knowing more about these allergies and identifying them early can help prevent serious reactions and improve the quality of life for affected children. Who this helps: Pediatricians and children with food allergies.

Plain English
This study examined a case of a 10-year-old girl who developed an allergic reaction after eating a fresh fig. It turned out that her fig allergy was linked to a protein similar to one found in dust mites, specifically Der p 1. The girl's tests showed she had a strong sensitivity to this dust mite protein (16.20 U/ml) and also to the fig protein, while other common allergens were negative. This matters because it highlights a rare but serious cross-reactivity that can occur between foods and environmental allergens, informing both patients and healthcare providers about potential allergenic risks. Who this helps: This helps patients with allergies, especially those who might unknowingly react to new foods.

Plain English
This research paper focuses on allergies to natural rubber latex (NRLA), which affects many healthcare workers and individuals at risk. The authors highlight that symptoms can vary from mild skin issues to severe, life-threatening reactions. They emphasize that preventing exposure is the best way to manage these allergies, but a specific treatment called desensitization can help change the course of the allergy. Who this helps: This research assists patients with latex allergies and healthcare workers at risk of exposure.

Plain English
This study looked at how a treatment called nickel oral hyposensitization (NiOHT) affects the quality of life for people with systemic nickel allergy syndrome (SNAS). Researchers found that after one year of treatment, patients reported a 20% improvement in their overall health-related quality of life. This is important because it shows that NiOHT can significantly help those suffering from this allergy feel better and improve their daily lives. Who this helps: This helps patients with systemic nickel allergy syndrome.

Plain English
Researchers studied a 48-year-old woman with eosinophilic esophagitis (EoE) and nickel allergy who did not improve with usual steroid treatment. After a year of treatment with nickel oral desensitization while following a nickel-free diet, her symptoms and inflammation completely resolved, allowing her to eat previously restricted foods again. This is significant because it shows that nickel desensitization can effectively treat EoE in patients with nickel allergies, which may help many others with similar conditions. Who this helps: This helps patients with eosinophilic esophagitis and nickel allergies.

Plain English
This study looked at how effective latex immunotherapy is for people allergic to natural rubber latex. Researchers treated 76 patients with this therapy for over three years and found that the size of skin reactions to latex decreased, along with specific allergy-related antibodies in the blood. This is important because it shows that this treatment can reduce allergy symptoms and improve quality of life for those affected. Who this helps: This benefits patients with latex allergies seeking relief from their symptoms.

Plain English
In this study, researchers looked at 13 patients with food allergies who underwent a treatment called specific oral desensitization to see if they could maintain their tolerance to certain foods after stopping the treatment. They found that all patients initially became desensitized, but when they stopped eating the allergens, 12 out of 13 had allergic reactions when they reintroduced these foods later. This indicates that the tolerance gained from the treatment is temporary, and regular consumption of the allergens is needed to keep that tolerance. Who this helps: This information benefits patients with food allergies and their doctors by clarifying the need for ongoing exposure to allergens after desensitization.

Plain English
In this study, researchers looked at how effective a treatment called profilin desensitization is for patients with allergies to plant-based foods. They treated seven patients by gradually increasing their exposure to profilin, and found that after the treatment, five patients had less severe allergic reactions when tested, and all of them could eat foods they previously couldn't without reacting. This matters because it shows that this treatment can help people manage their food allergies safely. Who this helps: Patients with plant-based food allergies.

Plain English
This study looked at whether a drug called ertapenem could be safely given to patients who are allergic to certain antibiotics known as β-lactams. Out of 49 patients tested, 35 were able to safely receive ertapenem after showing negative allergy tests. This is important because it suggests that many patients with β-lactam allergies may not need to avoid carbapenem antibiotics, which can be critical for treating infections. Who this helps: This benefits patients with β-lactam allergies who require antibiotic treatment.